h2o Therapeutics will soon be able to call on the marketing reach of pharma distributor AmerisourceBergen for its app for patients with Parkinson’s disease.
Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated.